Amedica Announces Launch of New Facet Joint Implant

SALT LAKE CITY, March 6, 2012 /PRNewswire via COMTEX/ — Amedica Corporation, a spinal and reconstructive implant and instrument manufacturer, focused on proprietary silicon nitride (Si3N4) ceramic technologies, announced today the launch of a new spinal implant called Procet(TM). Procet has been designed to treat patients who suffer from low back pain, caused by spinal stenosis.
The Procet Facet Allograft Implant system has a dual-hemispherical shape that limits motion while providing distraction; and unlike other products currently available, it is designed to remain stable in the joint, to increase the potential for fusion. This procedure provides surgeons a percutaneous, less invasive, early-stage treatment, which is particularly beneficial to elderly patients for whom more extensive open surgery may present too great a surgical risk.
Eric K. Olson, President and Chief Executive Officer, said, “The launch of the Procet system is an example of Amedica’s commitment to further expand our line of innovative facet products to support our surgeon customers and the patients they treat. Procet, in addition to our other facet products, showcases our company’s strength in developing state-of-the-art, minimally invasive medical products.”
Mr. Olson added, “This launch is also consistent with our strategy to increase sales of proprietary, IP-backed innovative products, which should drive improved gross margins and profitability.”
The Procet Facet Allograft Implants add to Amedica’s existing Facet Fixation System(TM) portfolio which includes the Javelin® MIS Facet Screw System and FacetGun® Max System.